Royal Marsden NHS Foundation Trust — CureCurrent

Published trials118

Recruiting shown13

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

Patient and Provider Perspectives on Genetic Risk ProfilingNCT07741929 · lead sponsor · 2026-05-01

Feasibility of Serial Multisite Image-guided Biopsy to Study Breast Cancer EvolutionNCT07084571 · lead sponsor · 2026-02-23

Assessing a Digital Exercise Intervention for Health Outcomes and Engagement in Regular ExerciseNCT07243834 · lead sponsor · 2025-12-16

Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung CancerNCT07008742 · lead sponsor · 2025-06-04

Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer PatientsNCT07673861 · lead sponsor · 2025-05-23

Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 FractionsNCT06638541 · lead sponsor · 2025-01-20

MIBREAST Making in Immediate Breast REconstruction And the Measurement of the EffectS of RadioTherapyNCT07136753 · lead sponsor · 2024-09-12

Breast Cancer Evolution During Neoadjuvant Systemic TherapyNCT06681064 · lead sponsor · 2024-05-29

Safe De-escalation of Chemotherapy for Stage 1 Breast CancerNCT05058183 · lead sponsor · 2023-06-05

The Man Van ProjectNCT06357416 · lead sponsor · 2022-04-13

A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast CancerNCT04985266 · lead sponsor · 2022-03-30

AI & Radiomics for Stratification of Lung Nodules After Radically Treated CancerNCT05375591 · lead sponsor · 2021-10-13

Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis StudyNCT05432739 · lead sponsor · 2021-04-07

Improving Engagement From Underserved Communities With Prostate Cancer Genetics ServicesNCT07407686 · lead sponsor · 2026-02-28

NOT_YET_RECRUITING

Prophylactic Prostatectomy for Prostate Cancer (PPPC)NCT06470685 · lead sponsor · 2024-06-24

ENROLLING_BY_INVITATION

Use of Artificial Intelligence in the Symptomatic BReAst Clinic SEttingNCT06578988 · lead sponsor · 2024-03-01

Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer PatientsNCT06019676 · lead sponsor · 2023-09-26

ACTIVE_NOT_RECRUITING

A Study Comparing Urolift and TURP Ahead of Radiotherapy in Men With Urinary Symptoms Secondary to Prostate EnlargementNCT05840549 · lead sponsor · 2023-05-09

Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA SuppressionNCT04920708 · lead sponsor · 2022-12-28

ACTIVE_NOT_RECRUITING

PINPOINT Feasibility StudyNCT05481372 · lead sponsor · 2022-08-01

Biological Characteristics of Older Women (> 70 Years) With ER Positive, HER2 Negative Early Breast CancerNCT05734950 · lead sponsor · 2022-07-21

Mapping Arterial Perforators Within the Breast During MammoplastyNCT06347952 · lead sponsor · 2022-04-27

PRELUDE Study of Lymphatic Surgery to Treat Breast Cancer Related LymphoedemaNCT04579029 · lead sponsor · 2021-10-13

Improving Diagnosis and Treatment of Metastatic Advanced Prostate CancerNCT04984395 · lead sponsor · 2021-07-30

Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19)NCT04721444 · lead sponsor · 2021-01-27

'Lung Health Check' Biomarker StudyNCT04957433 · lead sponsor · 2020-09-28

PIONEER Study of Lifestyle Intervention to Reduced Breast Cancer RiskNCT04574063 · lead sponsor · 2020-09-16

PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast CancerNCT04360941 · lead sponsor · 2020-08-11

ACTIVE_NOT_RECRUITING

Oncotype DX DCIS: Impact on Radiotherapy Decision MakingNCT06046664 · lead sponsor · 2020-07-07

Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC AdenocarcinomaNCT03361319 · lead sponsor · 2020-07-01

Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer TreatmentNCT04440800 · lead sponsor · 2020-07-01

Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid BiopsiesNCT04566614 · lead sponsor · 2020-06-18

Lung Nodule Imaging Biobank for Radiomics and AI ResearchNCT04270799 · lead sponsor · 2020-06-01

Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)NCT04427280 · lead sponsor · 2020-05-26

Generation Of a Lung Biobank for Future UseNCT05234138 · lead sponsor · 2019-10-31

Whole Body Magnetic Resonance Imaging StudyNCT04117594 · lead sponsor · 2019-10-09

Evaluating a Digital Tool for Supporting Breast Cancer PatientsNCT03866655 · lead sponsor · 2019-10-01

Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid TumoursNCT03620643 · lead sponsor · 2019-05-09

Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.NCT03644303 · lead sponsor · 2018-08-13

Prostate Radiotherapy Integrated With Simultaneous MRI (The PRISM Study)NCT03658525 · lead sponsor · 2018-08-07

PembRolIzuMab and Stereotactic Body Radiotherapy In Metastatic Non-small-cell lunG Cancer PatientsNCT03436056 · lead sponsor · 2018-03-01

SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung EffectsNCT03383302 · lead sponsor · 2018-02-08

MR-guided RAdiotherapy to Breast With Dose Escalation to regionaL Lymph NodEsNCT03405519 · lead sponsor · 2017-12-18

London Investigation Into diElectric Scanning of LesionsNCT03302819 · lead sponsor · 2017-11-01

Pilot Study for 3-Dimensional Surface Imaging in Implant-based Breast ReconstructionNCT03203252 · lead sponsor · 2017-06-09

Simulating Outcomes From Breast Conserving Surgery Using 3D Surface ImagingNCT03250260 · lead sponsor · 2017-05-01

Magnetic Resonance Breast Tissue Characterisation to Improve Risk Stratification for Breast CancerNCT03684733 · lead sponsor · 2017-03-13

A Trial Assessing Post-Operative Use of ProSpare, a Rectal Obturator in Prostate Cancer RadiotherapyNCT02978014 · lead sponsor · 2017-02-08

Combination Study of Guadecitabine/ASTX727 and PembrolizumabNCT02998567 · lead sponsor · 2017-01-26

ACTIVE_NOT_RECRUITING

The HeartSpare Plus 1B TrialNCT02771353 · lead sponsor · 2016-12-12

Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial OligometastasesNCT02759783 · lead sponsor · 2016-11-01

Pembrolizumab and Palliative Radiotherapy in LungNCT02587455 · lead sponsor · 2016-06-24

Tenovus Cancer Choirs Study: the Benefits of Singing for Those Affected by CancerNCT02756780 · lead sponsor · 2016-04-01

Evaluation Of CanADVICE+®M-Health System To Support Breast Cancer Patients Receiving CapecitabineNCT02580396 · lead sponsor · 2016-03-16

Primary Radiotherapy And DIEP flAp Reconstruction TrialNCT02771938 · lead sponsor · 2016-01-14

Impact of Radiotherapy on Patients Undergoing DIEP Flap Breast ReconstructionNCT03072316 · lead sponsor · 2016-01-14

Art Therapy for Pain Relief in Breast Cancer PatientsNCT02680236 · lead sponsor · 2015-06-01

The Use of 3D Surface Imaging in the Objective Assessment of Breast Conserving TherapyNCT02304614 · lead sponsor · 2015-04-01

PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclibNCT02389842 · lead sponsor · 2015-03-25

Development of a Personalised Care Plan Designed to Reduce Chronic Post-Operative Pain Following Breast SurgeryNCT02170415 · lead sponsor · 2014-06-01

Sponsor roles

lead sponsor88

collaborator30

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.